Nine points to consider to vote YES
This was on another board:
Here are some of the differences between the last attempt at a reverse split and this time:
(1) New Chief Executive Officer. While he been a member of the previous management team, Anna apparently made the decisions. The Board realized they weren't in the best interest and took action to remove her.
(2) The guy is smart enough to make DIFFERENT decisions. i.e. Focusing the company on the two core technologies and dispensing with the other products at this time. Not so under the previous Administration.
(3) Powerful and intellectual additions to the Board and advisors in science, medicine, FDA regulation, and financing.
(4) Most spin-offs on Wall Street are exceedingly successful by unlocking inherent value, hence the reason for the spin-off.
(5) Generex and/or their current shareholders will still reap these benefits.
(6) Both companies will be pure plays making it easier for the Market to evaluate them independently.
(7) The company they are buying throws off FREE CASH FLOW and increased revenue 30% year over year in an environment where competitors folded.
(8) Free cash flow can partially fund operations and testing leading to LESS dilution over time, and, in a synergistic fashion, make the company more appealing as an acquisition for Big Pharma.
(9) Although a segment invests in penny stocks and some companies evolve into very successful ventures, most of Wall Street abhors penny stocks. We need to consolidate the share structure to gain credibility, obtain analyst research and reporting, and more favorable financing.
Despite all the negativity on this board, there are many shareholders not as vocal who see a new promise and make the distinction between the past, the present, and what the future may hold. It is time to rally behind the new Administration with support. Perhaps they figured it out this time although they are up against anti-RV proponents who vividly remember the past and can't envision 'What if they are RIGHT?'
